These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 19067498

  • 1. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
    Sedjo RL, Cox ER.
    Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
    [Abstract] [Full Text] [Related]

  • 2. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
    Schneeweiss S, Patrick AR, Maclure M, Dormuth CR, Glynn RJ.
    Circulation; 2007 Apr 24; 115(16):2128-35. PubMed ID: 17420348
    [Abstract] [Full Text] [Related]

  • 3. Impact of statin copayments on adherence and medical care utilization and expenditures.
    Gibson TB, Mark TL, Axelsen K, Baser O, Rublee DA, McGuigan KA.
    Am J Manag Care; 2006 Dec 24; 12 Spec no.():SP11-9. PubMed ID: 17173486
    [Abstract] [Full Text] [Related]

  • 4. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation.
    Motheral BR, Henderson R.
    Am J Manag Care; 1999 Nov 24; 5(11):1383-94. PubMed ID: 10662412
    [Abstract] [Full Text] [Related]

  • 5. Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland.
    Helin-Salmivaara A, Korhonen MJ, Alanen T, Huupponen R.
    J Clin Pharm Ther; 2012 Feb 24; 37(1):58-64. PubMed ID: 21410736
    [Abstract] [Full Text] [Related]

  • 6. The effects of prescription drug copayments on statin adherence.
    Gibson TB, Mark TL, McGuigan KA, Axelsen K, Wang S.
    Am J Manag Care; 2006 Sep 24; 12(9):509-17. PubMed ID: 16961440
    [Abstract] [Full Text] [Related]

  • 7. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
    Ye X, Gross CR, Schommer J, Cline R, St Peter WL.
    Clin Ther; 2007 Dec 24; 29(12):2748-57. PubMed ID: 18201593
    [Abstract] [Full Text] [Related]

  • 8. Clinical and economic outcomes in patients switched to simvastatin in a community-based family medicine practice.
    Willey VJ, Reinhold JA, Willey KH, Kelly BL, Cziraky MJ.
    Int J Clin Pract; 2010 Aug 24; 64(9):1235-8. PubMed ID: 20653799
    [Abstract] [Full Text] [Related]

  • 9. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, Kokia E.
    Clin Ther; 2008 Nov 24; 30(11):2167-79. PubMed ID: 19108805
    [Abstract] [Full Text] [Related]

  • 10. Impact of decreasing copayments on medication adherence within a disease management environment.
    Chernew ME, Shah MR, Wegh A, Rosenberg SN, Juster IA, Rosen AB, Sokol MC, Yu-Isenberg K, Fendrick AM.
    Health Aff (Millwood); 2008 Nov 24; 27(1):103-12. PubMed ID: 18180484
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD, Rattinger GB, Kuznik A, Koren MJ.
    Clin Ther; 2008 Nov 24; 30 Pt 2():2204-16. PubMed ID: 19281915
    [Abstract] [Full Text] [Related]

  • 12. Are patent expirations the answer to improving patient adherence?
    Klepser DG.
    Am J Manag Care; 2008 Dec 24; 14(12):787-8. PubMed ID: 19067495
    [No Abstract] [Full Text] [Related]

  • 13. Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.
    Tran YB, Frial T, Miller PS.
    Can J Clin Pharmacol; 2007 Dec 24; 14(2):e205-14. PubMed ID: 17556788
    [Abstract] [Full Text] [Related]

  • 14. Moving from A to Z: successful implementation of a statin switch program by a large physician group.
    Sy FZ, Choe HM, Kennedy DM, Standiford CJ, Parsons DM, Bruhnsen KD, Stevenson JG, Bernstein SJ.
    Am J Manag Care; 2009 Apr 24; 15(4):233-40. PubMed ID: 19355796
    [Abstract] [Full Text] [Related]

  • 15. Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit.
    Rodin HA, Heaton AH, Wilson AR, Garrett NA, Plocher DW.
    Am J Manag Care; 2009 Dec 24; 15(12):881-8. PubMed ID: 20001169
    [Abstract] [Full Text] [Related]

  • 16. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.
    Maciejewski ML, Bryson CL, Perkins M, Blough DK, Cunningham FE, Fortney JC, Krein SL, Stroupe KT, Sharp ND, Liu CF.
    Am J Manag Care; 2010 Jan 01; 16(1):e20-34. PubMed ID: 20059288
    [Abstract] [Full Text] [Related]

  • 17. Use of diagnostic cluster methodology for therapeutic costing and drug surveillance of HMG-CoA reductase-inhibitor therapy.
    Bottorff MB, Yenkowsky JP, Cave DG.
    Clin Ther; 1999 Jan 01; 21(1):218-35. PubMed ID: 10090437
    [Abstract] [Full Text] [Related]

  • 18. Effect of statin adherence on cerebrovascular disease in primary prevention.
    Perreault S, Ellia L, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L.
    Am J Med; 2009 Jul 01; 122(7):647-55. PubMed ID: 19559167
    [Abstract] [Full Text] [Related]

  • 19. Effect of tiered prescription copayments on the use of preferred brand medications.
    Rector TS, Finch MD, Danzon PM, Pauly MV, Manda BS.
    Med Care; 2003 Mar 01; 41(3):398-406. PubMed ID: 12618643
    [Abstract] [Full Text] [Related]

  • 20. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations.
    Pittman DG, Chen W, Bowlin SJ, Foody JM.
    Am J Cardiol; 2011 Jun 01; 107(11):1662-6. PubMed ID: 21439533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.